2025-04-01 2026-03-31 2026-03-31 false 15567127 AMOTIO LTD 2026-04-29 32500 false iso4217:GBP xbrli:pure 15567127 2025-03-31 15567127 2026-03-31 15567127 2025-04-01 2026-03-31 15567127 2024-03-15 15567127 2025-03-31 15567127 2024-03-16 2025-03-31 15567127 bus:Micro-entities 2025-04-01 2026-03-31 15567127 bus:AuditExempt-NoAccountantsReport 2025-04-01 2026-03-31 15567127 bus:FullAccounts 2025-04-01 2026-03-31 15567127 bus:PrivateLimitedCompanyLtd 2025-04-01 2026-03-31 15567127 core:WithinOneYear 2026-03-31 15567127 core:AfterOneYear 2026-03-31 15567127 core:WithinOneYear 2025-03-31 15567127 core:AfterOneYear 2025-03-31 15567127 dpl:CostSales 2025-04-01 2026-03-31 15567127 dpl:AdministrativeExpenses 2025-04-01 2026-03-31 15567127 dpl:DistributionCosts 2025-04-01 2026-03-31 15567127 dpl:CostSales 2024-03-16 2025-03-31 15567127 dpl:AdministrativeExpenses 2024-03-16 2025-03-31 15567127 dpl:DistributionCosts 2024-03-16 2025-03-31 15567127 core:WithinOneYear 2026-03-31 15567127 core:AfterOneYear 2026-03-31 15567127 core:WithinOneYear 2025-03-31 15567127 core:AfterOneYear 2025-03-31 15567127 core:WithinOneYear 2025-04-01 2026-03-31 15567127 core:AfterOneYear 2025-04-01 2026-03-31 15567127 bus:Director1 2025-04-01 2026-03-31

AMOTIO LTD

Registered Number
15567127
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2026

AMOTIO LTD
Company Information
for the year from 1 April 2025 to 31 March 2026

Director | FOSTER, Iestyn

Registered Address | Springboard Business Innovation Centre Wales Llantarnam Park
| Cwmbran
| Torfaen
| NP44 3AW

Registered Number | 15567127 (England and Wales)

AMOTIO LTD
Balance Sheet as at
31 March 2026

|  | 2026 £ |  | 2025 £
--- | --- | --- | --- | ---
Fixed Assets |  | 29,272 |  | 35,038
Current Assets |  | 41,467 |  | 79,132
Prepayments and accrued income |  | 10,426 |  | 56,637
Creditors amounts falling due within one year |  | (55,685) |  | (8,412)
Net current assets (liabilities) |  | (3,792) |  | 127,357
Total assets less current liabilities |  | 25,480 |  | 162,395
Creditors amounts falling due after one year |  | (442,735) |  | (202,999)
Accruals and deferred income |  | - |  | (15,686)
Net assets (liabilities) |  | (417,255) |  | (56,290)
Capital and reserves |  | (417,255) |  | (56,290)

- The company is a private company limited by shares and registered in England and Wales. It was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
- The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
- The Director acknowledges their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
- These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

- Average number of employees

  The average number of persons employed by the company in the period was 5 (previous period: 3).

- Additional Disclosures

  The ultimate parent company is Amotio Health Ltd, whose bank balance at 31 March 2026 was £542,902. The company's principal activity is the research, development and manufacture (including outsourced manufacture), commercialisation, sale, distribution and marketing of medical devices — and related products and solutions — for the diagnosis and surgical treatment of disorders of the joints of the human skeleton, in particular (though not exclusively) the revision surgery of joint implants. Going concern The company is part of the well-funded Amotio group. Following the group's 2025 investment round, its parent, Amotio Health Limited, held cash funds of £542,902 at 31 March 2026 that are available to support the company's operations, and the company continues to attract non-dilutive grant funding, including a further instalment received since the year end. The directors have prepared cash flow forecasts, tested across a range of scenarios, which demonstrate that these group cash resources give the company a cash runway well in excess of twelve months from the date of approval; Amotio Health Limited has confirmed that the funds will remain available throughout that period. The company held net liabilities of £417,255 at 31 March 2026, consistent with its planned investment in product development. The directors are confident that the company has adequate resources to continue in operational existence for the foreseeable future, and the financial statements have accordingly been prepared on the going concern basis.

The financial statements were approved and authorised for issue by the Director on 29 April 2026, and are signed on its behalf by:
FOSTER, Iestyn Director Registered Company No. 15567127